Angolensin Isolated from Pterocarpus indicus Willd. Attenuates LPS-Induced Sickness Behaviors in Mice and Exhibits CNS Safety
International Journal of Molecular Sciences · 2025
DOI: 10.3390/ijms26104887 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von San Yoon Nwe und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacognosy and Pharmaceutical Botany, Faculty of Pharmaceutical Sciences, Chulalongkorn University, Bangkok 10330, Thailand. Hauptthemen laut MEDLINE: Lipopolysaccharides, Illness Behavior, Pterocarpus, Anti-Inflammatory Agents. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: 90th anniversary of the Chulalongkorn University Fund (Ratchadaphiseksomphot Endowment Fund).
Abstract (Originalsprache)
Folk medicine in Thailand has long made use of Pterocarpus indicus Willd. for treating inflammation-related disorders. However, scientific exploration of isolated compounds from P. indicus for improving inflammation-associated sickness conditions and their impact on central nervous system (CNS) safety remain unexplored. The present study initially screened the anti-neuroinflammatory effects of angolensin, a compound isolated from P. indicus heartwood in vitro. Following substantial findings, the efficacy of angolensin was further evaluated in a mouse model of lipopolysaccharide (LPS)-induced sickness behaviors, alongside an assessment of its CNS safety profiles. The anti-neuroinflammatory effects of angolensin were evaluated in LPS-induced BV-2 microglial cells. The effects of angolensin on sickness behaviors were examined in LPS-induced mice using the Laboratory Animal Behaviors Observation, Registration and Analysis System (LABORAS). Proinflammatory cytokine expression in plasma samples of mice was also determined. LABORAS and rotarod tests were conducted to investigate its impact on the CNS. In vitro assessment of the anti-inflammatory activity of angolensin on BV-2 microglial cells revealed a concentration-dependent reduction in the release of LPS-induced nitric oxide (NO) and proinflammatory cytokines (TNF-α and IL-6). At a concentration of 20 µM, angolensin showed comparable results to the positive control, 20 µM minocycline. In mice, angolensin significantly improved LPS-induced sickness behaviors, as indicated by improved home-cage behaviors. Consistent with the in vitro findings, angolensin attenuated the release of proinflammatory cytokines in the plasma of LPS-induced mice. Importantly, angolensin did not induce any adverse effects on locomotion, motor coordination, or general well-being, indicating a favorable CNS safety profile. Overall, these results highlight the anti-inflammatory potential of angolensin in mitigating sickness behaviors in mice, while demonstrating its CNS safety.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacognosy and Pharmaceutical Botany, Faculty of Pharmaceutical Sciences, Chulalongkorn University, Bangkok 10330, Thailand.
- Center of Excellence in DNA Barcoding of Thai Medicinal Plants, Faculty of Pharmaceutical Sciences, Chulalongkorn University, Bangkok 10330, Thailand.
- Department of Pharmacy, Faculty of Allied Health Sciences, University of Ruhuna, Galle 80000, Sri Lanka.
- Animal Models of Chronic Inflammation-Associated Diseases for Drug Discovery Research Unit, Faculty of Pharmaceutical Sciences, Chulalongkorn University, Bangkok 10330, Thailand.
- Department of Pharmacology and Physiology, Faculty of Pharmaceutical Sciences, Chulalongkorn University, Bangkok 10330, Thailand.
- Chulalongkorn School of Integrated Innovation, Chulalongkorn University, Bangkok 10330, Thailand.
ORCID-Profile: San Yoon Nwe, Peththa Wadu Dasuni Wasana, Hasriadi, Pasarapa Towiwat, Wisuwat Thongphichai, Boonchoo Sritularak, Suchada Sukrong
Förderung
- 90th anniversary of the Chulalongkorn University Fund (Ratchadaphiseksomphot Endowment Fund)
Zitieren
APA
Nwe, S. Y., Dasuni Wasana, P. W., Hasriadi, Towiwat, P., Thongphichai, W., Sritularak, B., & Sukrong, S. (2025). Angolensin Isolated from Pterocarpus indicus Willd. Attenuates LPS-Induced Sickness Behaviors in Mice and Exhibits CNS Safety. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26104887
Vancouver
Nwe SY, Dasuni Wasana PW, Hasriadi, Towiwat P, Thongphichai W, Sritularak B, et al. Angolensin Isolated from Pterocarpus indicus Willd. Attenuates LPS-Induced Sickness Behaviors in Mice and Exhibits CNS Safety. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26104887
BibTeX
@article{Nwe2025,
author = {Nwe, San Yoon and Dasuni Wasana, Peththa Wadu and Hasriadi and Towiwat, Pasarapa and Thongphichai, Wisuwat and Sritularak, Boonchoo and Sukrong, Suchada},
title = {Angolensin Isolated from Pterocarpus indicus Willd. Attenuates LPS-Induced Sickness Behaviors in Mice and Exhibits CNS Safety},
journal = {International Journal of Molecular Sciences},
year = {2025},
doi = {10.3390/ijms26104887}
}
EUVIMED